VectorVision will be exhibiting the highly popular CSV-1000HGT for standardized contrast sensitivity and glare testing alongside its European Distributor Trusetal (Trusetal Verbandstoffwerk GmbH) at the upcoming ESCRS meeting in Copenhagen. Dr. David Evans, Founder and CEO of VectorVision, will be available in Booth H116 from Sep. 10 to 13 providing demonstrations of the CSV-1000 and answering any …

At the recent ARVO meeting in Seattle, a number of vision scientists described studies in which significant vision loss could not be detected by standard visual acuity, but could be detected by contrast sensitivity and glare testing. Dr. Pinakin Davey of Western University School of Health Sciences, was interviewed about his findings by MDTV. He …

Over the last few years, a number of researchers have investigated various methods to improve visual performance. Beyond the traditional enhancements related to diminished focus. Glasses, contact lenses and refractive surgery (such as LASIK) improve visual performance in patients whose vision is blurry due solely todefocus. Although there has been a great deal of focused …

Recently published research from the Complutense University of Madrid showed that contrast sensitivity (CS) testing, as measured by the VectorVision CSV-1000, detected early vision loss in patients with mild Alzheimer’s. The researchers tested 26 Alzheimer’s patients and 28 age-matched normal subjects for visual acuity, color vision, contrast sensitivity and ocular coherence tomography (OCT). Results showed patients had …

VectorVision Inc. will be exhibiting at the upcoming ASCRS meeting in New Orleans, LA. This is the first time that ASCRS has been in New Orleans and provides an opportunity for VectorVision CEO Dr. David Evans to get back to his hometown (which he especially appreciates during crawfish and softshell crab season). ASCRS members in attendance …

In the December 2015 edition of EyeWorld Magazine, the official publication of the American Society of Cataract and Refractive Surgery, a number of eye surgeons discuss the importance of evaluating refractive and cataract patients using objective measures. Drs. Alio, Dexl, Kezirian and Lawless point out that while subjective patient assessment of visual outcomes is key, objective …

VectorVision will be attending the annual Caribbean Eye Meeting/ACES in Cancún, Jan. 28 – Feb. 2. Personnel will be available in the booth to demonstrate the CSV-1000S. Many ACES members currently utilize the CSV-1000S in their practices to better manage their cataract patients and educate them on why they might want cataract surgery sooner rather …

VectorVision will again be exhibiting at the upcoming Osher Cataract meeting, “Cataracts: Telling it Like it is.” The meeting — scheduled for January 13 – 17 — has grown substantially and has now been moved from Sarasota to a larger facility in Naples. A number of cataract surgeons attending the previous meetings have taken advantage …

Ophthalmology Times recently published an article in its U.S. and European editions emphasizing the importance of using real-world simulations to educate cataract patients and their families about cataractous vision loss. Cataract patients often cannot detect the vision loss because it occurs gradually over a number of years and affects both eyes equally. Further, standard high-contrast …

This year marks the 25th anniversary of VectorVision displaying its flagship standardized vision testing technology at the American Academy of Ophthalmology (AAO) meeting. The CSV-1000 instrument has gone through many revisions and updates since its debut to keep pace with the vision testing requirements of top-level eye care practitioners. The CSV-1000 remains the only standardized test for cataract …